Published TCIMAIL newest issue No.196
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 153437-55-9 | Product Number: W0021
WHI-P180 Hydrochloride
×
![]()
×
Purity: >97.0%(T)(HPLC)
Synonyms:
- 3-[(6,7-Dimethoxy-4-quinazolinyl)amino]phenol Hydrochloride
- 3-[(6,7-Dimethoxyquinazolin-4-yl)amino]phenol Hydrochloride
Product Documents:
| Size | Unit Price | Belgium | Japan* | Quantity |
|---|---|---|---|---|
| 25MG |
£139.00
|
Contact Us | 19 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
| Product Number | W0021 |
| Purity / Analysis Method | >97.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__1__5N__3O__3·HCl = 333.77 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive,Hygroscopic |
| CAS RN | 153437-55-9 |
| Reaxys Registry Number | 8592187 |
| PubChem Substance ID | 468593126 |
| MDL Number | MFCD09026915 |
Specifications
| Appearance | White to Light gray to Light yellow powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Water | max. 2.0 % |
| NMR | confirm to structure |
Properties (reference)
GHS
Related Laws:
Transport Information:
| HS Number | 2933599590 |
Application
WHI-P180 Hydrochloride: A Multi-Kinase Inhibitor
WHI-P180 (hydrochloride) is a multi-kinase inhibitor. There are reports that it inhibits rearranged during transfection (RET) kinase and kinase insert domain receptor (KDR), respectively.1) It also inhibits epidermal growth factor receptor (EGFR) as well as Janus Kinase 3 (JAK3).2,3) It inhibits IgE/antigen-induced vascular hyper-permeability,4) and cyclin-dependent kinase 2 (CDK2).5) In addition, it binds to tau-tubulin kinase 1 (TTBK1).6) (The product is for research purpose only.)
References
- 1) The discovery of 2-substituted phenol quinazolines as potent RET kinase inhibitors with improved KDR selectivity
- 2) 4-[(3-Bromo-4-hydroxyphenyl)amino]-6,7-dimethoxyquinazolin-1-ium chloride methanol solvate and 4-[(3-hydroxyphenyl)amino]-6,7-dimethoxy-1-quinazolinium chloride
- 3) Treatment of post-bone marrow transplant acute graft-versus-host disease with a rationally designed JAK3 inhibitor
- 4) Pharmacokinetics and biologic activity of the novel mast cell inhibitor, 4-(3'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline in mice
- 5) Binding mode of the 4-anilinoquinazoline class of protein kinase inhibitor: X-ray crystallographic studies of 4-anilinoquinazolines bound to cyclin-dependent kinase 2 and p38 kinase
- 6) X-ray structural analysis of tau-tubulin kinase 1 and its interactions with small molecular inhibitors
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.